Transient and late-life rapamycin for healthspan extension
Aging (Albany NY)
.
2020 Mar 12;12(5):4050-4051.
doi: 10.18632/aging.102947.
Epub 2020 Mar 12.
Authors
Ellen K Quarles
1
,
Peter S Rabinovitch
2
Affiliations
1
University of Michigan, Molecular, Cellular, and Developmental Biology Department, Ann Arbor, MI 48109, USA.
2
University of Washington, Pathology Department, Seattle, WA 98195, USA.
PMID:
32167485
PMCID:
PMC7093168
DOI:
10.18632/aging.102947
No abstract available
Keywords:
aging; healthspan; intermittent; persistence; rapamycin.
Publication types
Editorial
MeSH terms
Animals
Healthy Aging / drug effects*
Longevity / drug effects*
Sirolimus / pharmacology*
Substances
Sirolimus
Grants and funding
P01 AG001751/AG/NIA NIH HHS/United States
P30 AG013280/AG/NIA NIH HHS/United States
T32 AG000057/AG/NIA NIH HHS/United States